Page last updated: 2024-11-01

nimodipine and Anemia

nimodipine has been researched along with Anemia in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nyakas, C1
Buwalda, B1
Markel, E1
Korte, SM1
Luiten, PG1

Other Studies

1 other study available for nimodipine and Anemia

ArticleYear
Life-spanning behavioural and adrenal dysfunction induced by prenatal hypoxia in the rat is prevented by the calcium antagonist nimodipine.
    The European journal of neuroscience, 1994, May-01, Volume: 6, Issue:5

    Topics: Adrenal Insufficiency; Aging; Anemia; Animals; Behavior, Animal; Brain Damage, Chronic; Corticostero

1994